Tag Archives: NASDAQ:HQY

Healthequity (HQY) Receives a Buy from KeyBanc

KeyBanc analyst Donald Hooker reiterated a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $77.00. The company’s shares closed last Monday at $61.24. According to TipRanks.com, Hooker is ranked #473 out of 5715

Healthequity (HQY) Receives a Buy from Barrington

Barrington analyst Alexander Paris reiterated a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $75.00. The company’s shares closed last Monday at $62.89. According to TipRanks.com, Paris is currently ranked with no stars

A Director at Healthequity (NASDAQ: HQY) is Buying Shares

Today, a Director at Healthequity (HQY – Research Report), Robert Selander, bought shares of HQY for $610K. This recent transaction increases Robert Selander’s holding in the company by 44.11% to a total of $2.34 million. This is Selander’s first transaction

The Founder and Vice Chairman of Healthequity (NASDAQ: HQY) is Buying Shares

Today, the Founder and Vice Chairman of Healthequity (HQY – Research Report), Stephen Neeleman, bought shares of HQY for $610K. Following Stephen Neeleman’s last HQY Buy transaction on June 19, 2017, the stock climbed by 20.3%. In addition to Stephen

Healthequity (HQY) Received its Third Buy in a Row

After KeyBanc and Citigroup gave Healthequity (NASDAQ: HQY) a Buy rating last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Steven Halper reiterated a Buy rating on Healthequity today and set a price target of $80.

Why Did Cantor Fitzgerald Upgrade Healthequity’s Stock?

In a report released today, Steven Halper from Cantor Fitzgerald upgraded Healthequity (HQY – Research Report) to Buy, with a price target of $82. The company’s shares opened today at $59.63. Halper noted: “. We are upgrading the shares of